Ocular Therapeutix (OCUL) PT Lowered to $17 at BofA Securities, PT $17

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to Ocular Therapeutix (OCUL) PT Lowered to $17 at BofA Securities, PT $17

Raymond James Reiterates Strong Buy Rating on Ocular Therapeutix (OCUL), PT $19

March 3, 2025 11:47 AM EST

Raymond James analyst Dane Leone reiterated a Strong Buy rating and $19.00 price target on Ocular Therapeutix (NASDAQ: OCUL)

The analyst comments "Monday before Market Open, Ocular Therapeutix reported 4Q24 results. Management hosted a call to discuss progress. The company reported $17.1M in total revenue vs. our estimated $17.8M and diluted EPS of $(0.29) vs. our projected $(0.26). Revenues... More

Ocular Therapeutix (OCUL) Misses Q4 EPS by 4c

March 3, 2025 7:10 AM EST

Ocular Therapeutix (NASDAQ: OCUL) reported Q4 EPS of ($0.29), $0.04 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $17.08 million versus the consensus estimate of $17.21 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

... More